APOBEC3G expression is restricted to epithelial cells of the proximal convoluted tubules and is not expressed in the glomeruli of macaques

Journal of Histochemistry and Cytochemistry

Volumn 55, Issue 1, 2007, Pages 63-70

  Hill, M Sarah ^a   Ruiz, Autumn ^a   Gomez, Lisa M ^a   Miller, Jean Marie ^a   Berman, Nancy E J ^a   Stephens, Edward B ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

HIV 1; Nephropathy; Pathogenesis; SHIV; SIV

Indexed keywords

APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3G; CYTIDINE DEAMINASE; DOLICHOS BIFLORUS AGGLUTININ; LECTIN; MONOCLONAL ANTIBODY; PHASEOLUS VULGARIS ERYTHROAGGLUTININ; SODIUM CHLORIDE; UNCLASSIFIED DRUG; VIF PROTEIN;

ANIMAL TISSUE; ARTICLE; CELL LYSATE; CELL TYPE; CONTROLLED STUDY; GLOMERULUS; HIV ASSOCIATED NEPHROPATHY; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; KIDNEY CORTEX; KIDNEY DISEASE; KIDNEY EPITHELIUM; KIDNEY PROXIMAL TUBULE; MACACA; NONHUMAN; PERFUSION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; TISSUE SECTION; VIRUS CELL INTERACTION; VIRUS REPLICATION;

ANIMALS; CYTIDINE DEAMINASE; EPITHELIAL CELLS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; KIDNEY GLOMERULUS; KIDNEY TUBULES; MACACA NEMESTRINA; PHYTOHEMAGGLUTININS; PLANT LECTINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

DOLICHOS BIFLORUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MACACA; PHASEOLUS VULGARIS; SIMIAN IMMUNODEFICIENCY VIRUS; SIMIAN-HUMAN IMMUNODEFICIENCY VIRUS;

EID: 33845984002     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1369/jhc.6A7054.2006     Document Type: Article

References (50)

1. Alpers CE, Tsai CC, Hudkins KL, Cui Y, Kuller L, Benveniste RE, Ward JM, et al. (1997) Focal segmental glomerulosclerosis in primates infected with a simian immunodeficiency virus. AIDS Res Hum Retroviruses 13:413-424
2. Bagasra O, Lavi E, Bobroski L, Khalili K, Pestaner JP, Tawadros R, Pomerantz RJ (1996) Cellular reservoirs of HIV-1 in the central nervous system of infected individuals: identification by the combination of in situ polymerase chain reaction and immunohistochemistry. AIDS 10:573-585
3. Bruggeman LA, Dikman S, Meng C, Quaggin SE, Coffman TM, Klotman PE (1997) Nephropathy in human immunodeficiency virus-1 transgenic mice is due to renal transgene expression. J Clin Invest 100:84-92
4. Cohen AH, Sun NC, Shapshak P, Imagawa DT (1989) Demonstration of human immunodeficiency virus in renal epithelium in HIV-associated nephropathy. Mod Pathol. 2:125-128
5. D'Agati V, Appel GB (1997) HIV infection and the kidney. J Am Soc Nephrol 8:138-152
6. Doehle BP, Schafer A, Cullen BR (2005) Human APOBEC3B is a potent inhibitor of HIV-1 infectivity and is resistant to Vif. Virology 339:281-288
7. Dussart S, Courcoul M, Bessou G, Douaisi M, Duverger Y, Vigne R, Decroly E (2004) The Vif protein of human immunodeficiency virus type 1 is posttranslationally modified by ubiquitin. Biochem Biophys Res Com 315:66-72
8. Gattone VH, Tian C, Zhuge W, Sahni M, Narayan O, Stephens EB (1998) SIV-associated nephropathy in rhesus macaques infected with lymphocyte-tropic SIVmac239. AIDS Res Hum Retroviruses 14:1163-1180
9. Harris RS, Bishop KN, Sheehy AM, Craig HM, Petersen-Mahrt SK, Watt IN, Neuberger MS, et al. (2003) DNA deamination mediates innate immunity to retroviral infection. Cell 113:803-809
10. Hill MS, Mulcahy ER, Gomez ML, Pacyniak E, Berman NEJ, Stephens EB (2006) APOBEC3G expression is restricted to neurons in the brains of pigtailed macaques. AIDS Res Human Retroviruses 22:541-550
11. Husain M, D'Agati VD, He JC, Klotman ME, Klotman PE (2005) HIV-1 Nef induces dedifferentiation of podocytes in vivo: a characteristic feature of HIVAN. AIDS 19:1975-1980
12. Husain M, Gusella GL, Klotman ME, Gelman IH, Ross MD, Schwartz EJ, Cara A, et al. (2002) HIV-1 Nef induces proliferation and anchorage-independent growth in podocytes. J Am Soc Nephrol 13:1806-1815
13. Jarmuz A, Chester A, Bayliss J, Gisbourne J, Dunham I, Scott J, Navaratnam N (2002) An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22. Genomics 79:285-296
14. Kao S, Khan MA, Miyagi E, Plishka R, Buckler-White A, Strebel K (2003) The human immunodeficiency virus type 1 Vif protein reduces intracellular expression and inhibits packaging of APOBEC3G (CEM15), a cellular inhibitor of virus infectivity. J Virol 77:11398-11407
15. Liddament MT, Brown WL, Schumacher AJ, Harris RS (2004) APOBEC3F properties and hypermutation preferences indicate activity against HIV-1 in vivo. Curr Biol 14:1385-1391
16. Liu B, Yu X, Luo K, Yu Y, Yu XF (2004a) Influence of primate lentiviral Vif and proteasome inhibitors on human immunodeficiency virus type 1 virion packaging of APOBEC3G. J Virol 78:2072-2081
17. Liu Y, Liu H, Kim BO, Gattone VH, Li J, Nath A, Blum J, et al. (2004b) CD4-independent infection of astrocytes by human immunodeficiency virus type 1: requirement for the human mannose receptor. J Virol 78:4120-4133
18. KU2) that causes AIDS, neurological and renal disease in rhesus macaques. Virology 260:295-307
19. Lucas GM, Eustace JA, Sozio S, Mentari EK, Appiah KA, Moore RD (2004) Highly active antiretroviral therapy and the incidence of HIV-1-associated nephropathy: a 12-year cohort study. AIDS 18:541-546
20. Ludwig E, Silberstein FC, van Empel J, Erfle V, Neumann M, Brack-Werner R (1999) Diminished rev-mediated stimulation of human immunodeficiency virus type 1 protein synthesis is a hallmark of human astrocytes. J Virol 73:8279-8289
21. Mangeat B, Turelli P, Caron G, Friedli M, Perrin L, Trono D (2003) Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature 424:99-103
22. Mariani R, Chen D, Schrofelbauer B, Navarro F, Konig R, Bollman B, Munk C, et al. (2003) Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif. Cell 114:21-31
23. Marin M, Rose KM, Kozak SL, Kabat D (2003) HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation. Nat Med 9:1398-1403
24. Marras D, Bruggeman LA, Gao F, Tanji N, Mansukhani MM, Cara A, Ross MD, et al. (2002) Replication and compartmentalization of HIV-1 in kidney epithelium of patients with HIV-associated nephropathy. Nat Med 8:522-526
25. Mehle A, Strack B, Ancuta P, Zhang C, McPike M, Gabuzda D (2004) Vif overcomes the innate antiviral activity of APOBEC3G by promoting its degradation in the ubiquitin-proteasome pathway. J Biol Chem 279:7792-7798
26. Pardo V, Wetli CV, Strauss J, Bourgoignie JJ (1994) Renal complications of drug abuse and human immunodefeficiency virus. In Tisher CC, Brenner BM, eds. Renal Pathology: With Clinical and Functional Correlations. Philadelphia, J.B. Lippincott, 390-418
27. Rao TKS (1991) Clinical features of human immunodeficiency virus associated nephropathy. Kidney Int 40(suppl):13-18
28. Rao TKS, Filippone EJ, Nicastri AD, Landesman SH, Frank E, Chen CK, Freidman EA (1984) Associated focal and segmental glomerulosclerosis in the acquired immunodeficiency syndrome. N Engl J Med 310:669-673
29. Ray PE, Liu XH, Henry D, Dye III L, Xu L, Orenstein JM, Schuztbank TE (1998) Infection of human primary renal epithelial cells with HIV-1 from children with HIV-associated nephropathy. Kidney Int 53:1217-1229
30. Roling J, Schmid H, Fischereder M, Draenert R, Goebel FD (2006) HIV-associated renal diseases and highly active antiretroviral therapy-induced nephropathy. Clin Infect Dis 42:1488-1495
31. Savin VJ, Terreros DA (1981) Filtration in single isolated mammalian glomeruli. Kidney Int 20:188-197
32. Sawyer SL, Emerman M, Malik HS (2004) Ancient adaptive evolution of the primate antiviral DNA-editing enzyme APOBEC3G. PLoS Biol 2:E275
33. Schwartz EJ, Cara A, Snoeck H, Ross MD, Sunamoto M, Reiser J, Mundel P, et al. (2001) Human immunodeficiency virus-1 induces loss of contact inhibition in podocytes. J Am Soc Nephrol 12:1677-1684
34. Sheehy AM, Gaddis NC, Choi JD, Malim MH (2002) Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418:646-650
35. Sheehy AM, Gaddis NC, Malim MH (2003) The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif. Nat Med 9:1404-1407
36. Stephens EB, Tian C, Dalton SB, Gattone VH 2nd (2000) Simian-human immunodeficiency virus-associated nephropathy in macaques. AIDS Res Hum Retroviruses 16:1295-1306
37. Stephens EB, Tian C, Li Z, Narayan O, Gattone VH (1998) Rhesus macaques infected with macrophage-tropic simian immunodeficiency virus (SIVmacR71/17E) exhibit extensive focal segmental and global glomerulosclerosis. J Virol 72:8820-8832
38. Stopak K, de Noronha C, Yonemoto W, Greene WC (2003) HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability. Mol Cell 12:591-601
39. Sunamoto M, Husain M, He JC, Schwartz EJ, Klotman PE (2003) Critical role for Nef in HIV-1-induced podocyte dedifferentiation. Kidney Int 64:1695-1701
40. Tanji N, Ross MD, Tanji K, Bruggeman LA, Markowitz GS, Klotman PE, D'Agati VD (2006) Detection and localization of HIV-1 DNA in renal tissues by in situ polymerase chain reaction. Histol Histopathol 21:393-401
41. Tornatore C, Chandra R, Berger JR, Major EO (1994) HIV-1 infection of subcortical astrocytes in the pediatric central nervous system. Neurology 44:481-487
42. Wiegand HL, Doehle BP, Bogerd HP, Cullen BR (2004) A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins. EMBO J 23:2451-2488
43. Winston JA, Klotman PE (1996) Are we missing an epidemic of HIV-associated nephropathy. J Am Soc Nephrol 7:1-7
44. Winston JA, Klotman ME, Klotman PE (1999) HIV-associated nephropathy is a late, not early, manifestation of HIV-1 infection. Kidney Int 55:1036-1040
45. Yu Q, Chen D, Konig R, Mariani R, Unutmaz D, Landau NR (2004a) APOBEC3B and APOBEC3C are potent inhibitors of simian immunodeficiency virus replication. J Biol Chem 279:53379-53386
46. Yu Q, Konig R, Pillai S, Chiles K, Kearney M, Palmer S, Richman D, et al. (2004b) Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome. Nat Struct Mol Biol 11:435-442
47. Yu X, Yu Y, Liu B, Luo K, Kong W, Mao P, Yu XF (2003) Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex. Science 302:1056-1060
48. Zhang H, Yang B, Pomerantz RJ, Zhang C, Arunachalam SC, Gao L (2003) The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA. Nature 424:94-98
49. Zheng YH, Irwin D, Kurosu T, Tokunaga K, Sata T, Peterlin BM (2004) Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication. J Virol 78:6073-6076
50. Zhong J, Zuo Y, Ma J, Fogo AB, Jolicoeur P, Ichikawa I, Matsusaka T (2005) Expression of HIV-1 genes in podocytes alone can lead to the full spectrum of HIV-1-associated nephropathy. Kidney Int 68:1048-1060